期刊文献+

经内镜逆行胰胆管造影术后并发症的危险因素分析 被引量:19

Risk factors for ERCP-related complications: a review of 1 951 cases
原文传递
导出
摘要 目的探讨经内镜逆行胰胆管造影术(ERCP)术后并发症的危险因素。方法回顾性分析2011年1月1日到2013年12月31日于南昌大学第一附属医院消化内镜中心行ERCP的1951例住院患者资料,对于ERCP出现并发症的病例行单因素及多因素分析,探讨ERCP术后并发症的危险因素。结果1951例病例中,出现并发症277例。ERCP术后胰腺炎101例(5.18%);并发高淀粉血症(不包括胰腺炎)54例(2.77%);并发胆道感染134例(6.87%);并发上消化道出血8例(0.41%),并发肠梗阻1例(0.05%)及十二指肠穿孔1例(0.05%)。多因素分析显示胆管癌(P=0.002,OR=2.39,95%CI:1.38~4.14)、ERCP手术时间超过60min(P=0.020,OR=3.77,95%CI:1.23—11.53)、内镜下乳头括约肌切开术(EST)(P=0.008,OR=2.56,95%CI:1.28~5.14)、ERCP术中导丝进入胰管(P=0.012,OR:1.43,95%CI:1.08~1.87)为术后胰腺炎的独立危险因素;胆管癌(P〈0.01,OR=2.93,95%CI:1.88~4.56)及住院期间多次行ERCP(P〈0.01,OR=2.53,95%CI:1.63~3.93)为术后胆道感染的独立危险因素,行EST(P=0.03,OR=0.65,95%CI:0.44~0.97)及ERCP术后预防性使用抗生素(P=0.03,OR=0.64,95%CI:0.39~0.95)为术后胆道感染的保护因素。结论胆管癌、行EST、ERCP手术时间超过60min及术中导丝等器械进入胰管均易发生ERCP术后胰腺炎。胆管癌、住院期间多次行ERCP术易增加ERCP术后胆道感染的发生,而行EST及术后预防性使用抗生素可减少术后胆道感染的发生。 Objective To investigate the risk factors for post-ERCP complications. Methods Data of the patients who underwent ERCP in the First Affiliated Hospital of Nanchang University from 1 January 2011 to 31 December 2013 were retrospectively analyzed. Post-ERCP complications were analyzed by univariate and multivariate analyses. Results A total of 277 patients out of 1 951 developed complications, 101 ( 5. 18%) pancreatitis, 54 (2.77%) hyperamylasemia ( not including pancreatitis ), 134 ( 6. 87%) biliary infection, 8 (0.41%) hemorrhage, 1 (0.05%) obstruction and i (0.05%) perforation. Multivariate analyses showed cholangiocarcinoma (P= 0. 002, OR= 2. 39, 95% CI: 1.38-4. 14) , long operation time( 〉 60 min) (P=0. 020, 0R=3.77, 95%CI:1.23-11.53) and endoscopic sphincterotomy (EST) (P=0. 008, OR= 2. 56, 95% CI: 1.28-5. 14) and entrance of guidewire to pancreatic duct ( P = 0. 0i2, OR = 1.43, 95%C1:1.08-1.87) were independent risk factors for PEP. Cholangiocarcinoma (P〈 0. 01, OR = 2. 93, 95%C1: 1.88-4. 56) , multiple times of ERCP during the period of hospitalization ( P〈0. 01, OR = 2. 53, 95%CI: 1.63-3.93) were independent risk factors for post-cholangitis. However, EST ( P = 0. 03, OR =0. 65,95% CI:0. 44-0. 97) and antibiotics prophylaxis after ERCP ( P = 0. 03, OR = 0. 64, 95% CI: 0. 39- 0. 95 ) were protective factors for post-cholangitis. Conclusion Cholangiocarcinoma, endoscopic sphincterotomy, long operation time (〉 60 min ) and entrance of guidewire to pancreatic duct were independent risk factors for PEP. Cholangiocarcinoma and multiple ERCP during the period of hospitalization are independent risk factors for post-cholangitis. EST and antibiotics prophylaxis after ERCP might reduce the occurrence of cholangitis.
出处 《中华消化内镜杂志》 CSCD 北大核心 2017年第10期732-737,共6页 Chinese Journal of Digestive Endoscopy
基金 江西省科技计划项目(20141BBG70020)
关键词 经内镜逆行胰胆管造影术 经内镜逆行胰胆管造影术后胰腺炎 胆道感染 危险因素 Endoscopic retrograde cholangiopancreatography Post-ERCP pancreatitis Biliaryinfection Risk factors
  • 相关文献

参考文献2

二级参考文献17

  • 1Ayman M Abdel Aziz,Glen A Lehman.Pancreatits after endoscopic retrograde cholangio-pancreatography[J].World Journal of Gastroenterology,2007,13(19):2655-2668. 被引量:19
  • 2Anderson DJ, Shimpi RA, McDonald JR,et al. Infectious complication following endoscopic retrograde cholangiopancreatography: an automated surveillance system for detecting postprocedure bacteremia. Am J Infect,2008, 36:592-594.
  • 3Novello P, Hagege H, Ducreux M, et al. Septicemias after endoscopic retrograde cholanglopancrcatography. Risk factors and antibiotic prophylaxis. Gastroenterol Clin Biol, 1993,17:897-902.
  • 4Classen DC, Jacobson JA, Burke JP,et al. Serious Pseudomonas infections associated with endoscopic retrograde cholangiopancreatography. Am J Med, 1988,84:590-596.
  • 5Abhishek Choudhary,Matthew L. Bechtold,Murtaza Arif,Nicholas M. Szary,Srinivas R. Puli,Mohamed O. Othman,Wilson P. Pais,Mainor R. Antillon,Praveen K. Roy.Pancreatic stents for prophylaxis against post-ERCP pancreatitis: a meta-analysis and systematic review[J].Gastrointestinal Endoscopy.2011(2)
  • 6Rita Conigliaro,Raffaele Manta,Helga Bertani,Mauro Manno,Carmelo Barbera,Angelo Caruso,Giampiero Olivetti,Gianluigi Melotti,Marzio Frazzoni.Pancreatic duct stenting for the duration of ERCP only does not prevent pancreatitis after accidental pancreatic duct cannulation: a prospective randomized trial[J].Surgical Endoscopy.2013(2)
  • 7Xiwei Ding,Min Chen,Shuling Huang,Song Zhang,Xiaoping Zou.Nonsteroidal anti-inflammatory drugs for prevention of post-ERCP pancreatitis: a meta-analysis[J].Gastrointestinal Endoscopy.2012(6)
  • 8Tae Hoon Lee,Jong Ho Moon,Hyun Jong Choi,Seung Hyo Han,Young Koog Cheon,Young Deok Cho,Sang-Heum Park,Sun-Joo Kim.Prophylactic temporary 3F pancreatic duct stent to prevent post-ERCP pancreatitis in patients with a difficult biliary cannulation: a multicenter, prospective, randomized study[J].Gastrointestinal Endoscopy.2012(3)
  • 9Sang-Woo Cha,Wesley D. Leung,Glen A. Lehman,James L. Watkins,Lee McHenry,Evan L. Fogel,Stuart Sherman.Does leaving a main pancreatic duct stent in place reduce the incidence of precut biliary sphincterotomy–associated pancreatitis? A randomized, prospective study[J].Gastrointestinal Endoscopy.2012
  • 10Taiga Otsuka,Seiji Kawazoe,Shunya Nakashita,Saori Kamachi,Satoshi Oeda,Chinatsu Sumida,Takumi Akiyama,Keisuke Ario,Masaru Fujimoto,Masanobu Tabuchi,Takahiro Noda.Low-dose rectal diclofenac for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized controlled trial[J].Journal of Gastroenterology.2012(8)

共引文献22

同被引文献164

引证文献19

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部